1949 related articles for article (PubMed ID: 30659978)
1. Cellular senescence in bone.
Farr JN; Khosla S
Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
[TBL] [Abstract][Full Text] [Related]
2. Identification of Senescent Cells in the Bone Microenvironment.
Farr JN; Fraser DG; Wang H; Jaehn K; Ogrodnik MB; Weivoda MM; Drake MT; Tchkonia T; LeBrasseur NK; Kirkland JL; Bonewald LF; Pignolo RJ; Monroe DG; Khosla S
J Bone Miner Res; 2016 Nov; 31(11):1920-1929. PubMed ID: 27341653
[TBL] [Abstract][Full Text] [Related]
3. Targeting Cell Senescence for the Treatment of Age-Related Bone Loss.
Pignolo RJ; Samsonraj RM; Law SF; Wang H; Chandra A
Curr Osteoporos Rep; 2019 Apr; 17(2):70-85. PubMed ID: 30806947
[TBL] [Abstract][Full Text] [Related]
4. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
[TBL] [Abstract][Full Text] [Related]
5. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
Lagoumtzi SM; Chondrogianni N
Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
[TBL] [Abstract][Full Text] [Related]
6. Independent Roles of Estrogen Deficiency and Cellular Senescence in the Pathogenesis of Osteoporosis: Evidence in Young Adult Mice and Older Humans.
Farr JN; Rowsey JL; Eckhardt BA; Thicke BS; Fraser DG; Tchkonia T; Kirkland JL; Monroe DG; Khosla S
J Bone Miner Res; 2019 Aug; 34(8):1407-1418. PubMed ID: 30913313
[TBL] [Abstract][Full Text] [Related]
7. Osteocyte Cellular Senescence.
Farr JN; Kaur J; Doolittle ML; Khosla S
Curr Osteoporos Rep; 2020 Oct; 18(5):559-567. PubMed ID: 32794138
[TBL] [Abstract][Full Text] [Related]
8. Cellular senescence: a key therapeutic target in aging and diseases.
Zhang L; Pitcher LE; Yousefzadeh MJ; Niedernhofer LJ; Robbins PD; Zhu Y
J Clin Invest; 2022 Aug; 132(15):. PubMed ID: 35912854
[TBL] [Abstract][Full Text] [Related]
9. A tale of the good and bad: Cell senescence in bone homeostasis and disease.
Liu X; Wan M
Int Rev Cell Mol Biol; 2019; 346():97-128. PubMed ID: 31122396
[TBL] [Abstract][Full Text] [Related]
10. Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations.
Schafer MJ; Haak AJ; Tschumperlin DJ; LeBrasseur NK
Curr Rheumatol Rep; 2018 Jan; 20(1):3. PubMed ID: 29374361
[TBL] [Abstract][Full Text] [Related]
11. Cellular Senescence: A Translational Perspective.
Kirkland JL; Tchkonia T
EBioMedicine; 2017 Jul; 21():21-28. PubMed ID: 28416161
[TBL] [Abstract][Full Text] [Related]
12. Targeting cellular senescence prevents age-related bone loss in mice.
Farr JN; Xu M; Weivoda MM; Monroe DG; Fraser DG; Onken JL; Negley BA; Sfeir JG; Ogrodnik MB; Hachfeld CM; LeBrasseur NK; Drake MT; Pignolo RJ; Pirtskhalava T; Tchkonia T; Oursler MJ; Kirkland JL; Khosla S
Nat Med; 2017 Sep; 23(9):1072-1079. PubMed ID: 28825716
[TBL] [Abstract][Full Text] [Related]
13. "Bone-SASP" in Skeletal Aging.
Fang CL; Liu B; Wan M
Calcif Tissue Int; 2023 Jul; 113(1):68-82. PubMed ID: 37256358
[TBL] [Abstract][Full Text] [Related]
14. Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics.
Chandra A; Rajawat J
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805567
[TBL] [Abstract][Full Text] [Related]
15. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
Khalil R; Diab-Assaf M; Lemaitre JM
Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
[TBL] [Abstract][Full Text] [Related]
16. A guide to senolytic intervention in neurodegenerative disease.
Lee S; Wang EY; Steinberg AB; Walton CC; Chinta SJ; Andersen JK
Mech Ageing Dev; 2021 Dec; 200():111585. PubMed ID: 34627838
[TBL] [Abstract][Full Text] [Related]
17.
Samakkarnthai P; Saul D; Zhang L; Aversa Z; Doolittle ML; Sfeir JG; Kaur J; Atkinson EJ; Edwards JR; Russell GG; Pignolo RJ; Kirkland JL; Tchkonia T; Niedernhofer LJ; Monroe DG; Lebrasseur NK; Farr JN; Robbins PD; Khosla S
Aging (Albany NY); 2023 May; 15(9):3331-3355. PubMed ID: 37154858
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of senescent cell secretomes to identify common and specific features of the different senescent phenotypes: a tool for developing new senotherapeutics.
Oguma Y; Alessio N; Aprile D; Dezawa M; Peluso G; Di Bernardo G; Galderisi U
Cell Commun Signal; 2023 Sep; 21(1):262. PubMed ID: 37770897
[TBL] [Abstract][Full Text] [Related]
19. Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.
Robbins PD; Jurk D; Khosla S; Kirkland JL; LeBrasseur NK; Miller JD; Passos JF; Pignolo RJ; Tchkonia T; Niedernhofer LJ
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():779-803. PubMed ID: 32997601
[TBL] [Abstract][Full Text] [Related]
20. Senotherapeutics: emerging strategy for healthy aging and age-related disease.
Kim EC; Kim JR
BMB Rep; 2019 Jan; 52(1):47-55. PubMed ID: 30526770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
